TCL Archive In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs July 11, 1975
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases October 1, 1999